Ethnicity and lupus nephritis: An Australian single centre study

Internal Medicine Journal

Volumn 41, Issue 3, 2011, Pages 270-278

  Ong, C ^a   Nicholls, K ^a   Becker, G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Ethnicity; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; AUSTRALIA; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEGRO; NEPHRITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; AUSTRALIA; COHORT STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79953012253     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02159.x     Document Type: Article

References (31)

1. Lea JPMD. Lupus nephritis in African Americans. Am J Med Sci 2002; 323: 85-9.
2. Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K etal. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 2006; 69: 1846-51.
3. Alarcon GS, Bastian HM, Beasley TM, Roseman JM, Tan FK, Fessler BJ etal. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA): contributions of admixture and socioeconomic status to renal involvement. Lupus 2006; 15: 26-31.
4. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 1997; 51: 1188-95.
5. Bihl GR, Petri M, Fine DM. Kidney biopsy in lupus nephritis: look before you leap. Nephrol Dial Transplant 2006; 21: 1749-52.
6. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthritis Rheum 1995; 38: 551-8.
7. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994; 53: 675-80.
8. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-2.
9. Patel M, Clarke AM, Bruce IN, Symmons DPM. The prevalence and incidence of biopsy-proven lupus nephritis in the UK - evidence of an ethnic gradient. Arthritis Rheum 54: 2963-9.
10. Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. Lupus 2007; 16: 830-7.
11. Boers A, Qiang L, Wong M, Miller M, Littlejohn G. Differences in SLE disease activity between patients of Caucasian and South-East Asian/Chinese background in an Australian hospital. APLAR J Rheumatol 2006; 9: 43-8.
12. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 2001; 10: 439-44.
13. Bloor G, Rigby RJ, Richmond JM, Zilko PJ, Dawkins RL. Systemic lupus erythematosus in Australian Aborigines. Aust N Z J Med 1982; 12: 553-8.
14. Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust N Z J Med 1993; 23: 646-51.
15. Bossingham D. Systemic lupus erythematosus in the far north of Queensland. Lupus 2003; 12: 327-31.
16. Lau CS. Lupus in Asia: how much do we know? APLAR J Rheumatol 2006; 9: 313-14.
17. Chen S-L. Why a special Asia Pacific issue on systemic lupus erythematosus? Perspectives from China. APLAR J Rheumatol 2006; 9: 315-16.
18. Frank AO. Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia. Ann Rheum Dis 1980; 39: 266-9.
19. Thumboo J, Wee H-L. Systemic lupus erythematosus in Asia: is it more common and more severe? APLAR J Rheumatol 2006; 9: 320-6.
20. Phan JC, Bush TM, Donald F, Ward M. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus. Lupus 1999; 8: 521.
21. Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J etal. Systemic Lupus Erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998; 41: 1161-72.
22. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB etal. Cell Biology - Immunology - Pathology: the classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-30.
23. Melbourne Health Quality of Care Report 2006/07. Available from URL:
24. Victorian Government Health Information: Public Hospitals. Available from URL:
25. Devaney A, Tomson C. Chronic kidney disease - new approaches to classification. Hosp Pharm 2006; 13: 406-10.
26. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V, Lolekha P etal. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol 2005; 16: 791-9.
27. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56: 481-90.
28. Deafen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P etal. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-18.
29. Kamat SS, Pepmueller PH, Moore TL. Triplets with systemic lupus erythematosus. Arthritis Rheum 2003; 48: 3176-80.
30. Zhang B, Xu X-W, Zeng X-J, Li D-K. Correlation of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentration in Han Chinese patients treated with azathioprine 25-100mg: a 1-year, single-center, prospective study. Curr Ther Res 2006; 67: 270-82.
31. Heckmann JM, Lambson EMT, Little F, Owen EP. Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events. J Neurol Sci 2005; 231: 71-80.